nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Carbachol—glaucoma	0.552	0.866	CbGbCtD
Orlistat—CYP3A4—Pilocarpine—glaucoma	0.0201	0.0316	CbGbCtD
Orlistat—ABHD12—optic choroid—glaucoma	0.0193	0.528	CbGeAlD
Orlistat—CYP3A4—Brinzolamide—glaucoma	0.0158	0.0248	CbGbCtD
Orlistat—CYP3A4—Dorzolamide—glaucoma	0.0153	0.0239	CbGbCtD
Orlistat—CYP3A4—Methazolamide—glaucoma	0.0136	0.0213	CbGbCtD
Orlistat—CYP3A4—Acetazolamide—glaucoma	0.0109	0.017	CbGbCtD
Orlistat—CYP3A4—Clonidine—glaucoma	0.00983	0.0154	CbGbCtD
Orlistat—PLA2G7—connective tissue—glaucoma	0.00427	0.116	CbGeAlD
Orlistat—ABHD12—eye—glaucoma	0.00389	0.106	CbGeAlD
Orlistat—ABHD12—retina—glaucoma	0.00386	0.105	CbGeAlD
Orlistat—PNLIP—connective tissue—glaucoma	0.00375	0.102	CbGeAlD
Orlistat—PLA2G4A—connective tissue—glaucoma	0.00151	0.0413	CbGeAlD
Orlistat—PLA2G4A—Pindolol—Carteolol—glaucoma	0.00112	0.276	CbGdCrCtD
Orlistat—PLA2G4A—Pindolol—Levobunolol—glaucoma	0.00112	0.276	CbGdCrCtD
Orlistat—PLA2G4A—Pindolol—Metipranolol—glaucoma	0.00107	0.264	CbGdCrCtD
Orlistat—PLA2G4A—Pindolol—Betaxolol—glaucoma	0.000749	0.184	CbGdCrCtD
Orlistat—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000223	0.000976	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Travoprost—glaucoma	0.000222	0.000971	CcSEcCtD
Orlistat—FASN—AMPK Signaling—TP53—glaucoma	0.000221	0.00237	CbGpPWpGaD
Orlistat—Insomnia—Dorzolamide—glaucoma	0.000221	0.000968	CcSEcCtD
Orlistat—Gastrointestinal disorder—Brimonidine—glaucoma	0.000221	0.000968	CcSEcCtD
Orlistat—Fatigue—Brimonidine—glaucoma	0.000221	0.000967	CcSEcCtD
Orlistat—PNLIP—Metabolism—CA2—glaucoma	0.000221	0.00237	CbGpPWpGaD
Orlistat—Feeling abnormal—Acetazolamide—glaucoma	0.00022	0.000963	CcSEcCtD
Orlistat—Hypersensitivity—Apraclonidine—glaucoma	0.00022	0.000962	CcSEcCtD
Orlistat—Paraesthesia—Dorzolamide—glaucoma	0.00022	0.000961	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000219	0.000959	CcSEcCtD
Orlistat—Pain—Brimonidine—glaucoma	0.000219	0.000959	CcSEcCtD
Orlistat—Insomnia—Brinzolamide—glaucoma	0.000217	0.000952	CcSEcCtD
Orlistat—Muscle spasms—Clonidine—glaucoma	0.000217	0.000952	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—OPN4—glaucoma	0.000217	0.00233	CbGpPWpGaD
Orlistat—Paraesthesia—Brinzolamide—glaucoma	0.000216	0.000945	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000216	0.00231	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000216	0.00231	CbGpPWpGaD
Orlistat—Dyspepsia—Dorzolamide—glaucoma	0.000215	0.000943	CcSEcCtD
Orlistat—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000215	0.0023	CbGpPWpGaD
Orlistat—Upper respiratory tract infection—Timolol—glaucoma	0.000214	0.000939	CcSEcCtD
Orlistat—Dyspepsia—Travoprost—glaucoma	0.000214	0.000938	CcSEcCtD
Orlistat—Asthenia—Apraclonidine—glaucoma	0.000214	0.000937	CcSEcCtD
Orlistat—Vision blurred—Clonidine—glaucoma	0.000213	0.000933	CcSEcCtD
Orlistat—Decreased appetite—Dorzolamide—glaucoma	0.000213	0.000931	CcSEcCtD
Orlistat—Urticaria—Acetazolamide—glaucoma	0.000212	0.000928	CcSEcCtD
Orlistat—Dyspepsia—Brinzolamide—glaucoma	0.000212	0.000927	CcSEcCtD
Orlistat—Pruritus—Apraclonidine—glaucoma	0.000211	0.000924	CcSEcCtD
Orlistat—Body temperature increased—Acetazolamide—glaucoma	0.000211	0.000923	CcSEcCtD
Orlistat—Fatigue—Dorzolamide—glaucoma	0.000211	0.000923	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00021	0.000922	CcSEcCtD
Orlistat—Gastrointestinal disorder—Travoprost—glaucoma	0.00021	0.00092	CcSEcCtD
Orlistat—Fatigue—Travoprost—glaucoma	0.00021	0.000919	CcSEcCtD
Orlistat—Ill-defined disorder—Clonidine—glaucoma	0.00021	0.000919	CcSEcCtD
Orlistat—Pain—Dorzolamide—glaucoma	0.000209	0.000916	CcSEcCtD
Orlistat—Insomnia—Pilocarpine—glaucoma	0.000209	0.000915	CcSEcCtD
Orlistat—Decreased appetite—Brinzolamide—glaucoma	0.000209	0.000915	CcSEcCtD
Orlistat—Pain—Travoprost—glaucoma	0.000208	0.000912	CcSEcCtD
Orlistat—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000208	0.000909	CcSEcCtD
Orlistat—Paraesthesia—Pilocarpine—glaucoma	0.000207	0.000908	CcSEcCtD
Orlistat—Asthenia—Bimatoprost—glaucoma	0.000207	0.000908	CcSEcCtD
Orlistat—Fatigue—Brinzolamide—glaucoma	0.000207	0.000908	CcSEcCtD
Orlistat—Angioedema—Clonidine—glaucoma	0.000207	0.000905	CcSEcCtD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGS2—glaucoma	0.000207	0.00221	CbGpPWpGaD
Orlistat—Pain—Brinzolamide—glaucoma	0.000206	0.0009	CcSEcCtD
Orlistat—Depression—Timolol—glaucoma	0.000205	0.000898	CcSEcCtD
Orlistat—Pruritus—Bimatoprost—glaucoma	0.000205	0.000896	CcSEcCtD
Orlistat—Immune system disorder—Betaxolol—glaucoma	0.000204	0.000894	CcSEcCtD
Orlistat—Diarrhoea—Apraclonidine—glaucoma	0.000204	0.000894	CcSEcCtD
Orlistat—FASN—Disease—HEYL—glaucoma	0.000204	0.00219	CbGpPWpGaD
Orlistat—FASN—Disease—FGFR1OP—glaucoma	0.000204	0.00219	CbGpPWpGaD
Orlistat—Malaise—Clonidine—glaucoma	0.000204	0.000893	CcSEcCtD
Orlistat—Mediastinal disorder—Betaxolol—glaucoma	0.000204	0.000892	CcSEcCtD
Orlistat—Dyspepsia—Pilocarpine—glaucoma	0.000203	0.000891	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HEYL—glaucoma	0.000202	0.00216	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP1—glaucoma	0.000202	0.00216	CbGpPWpGaD
Orlistat—Feeling abnormal—Dorzolamide—glaucoma	0.000201	0.000882	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—SMO—glaucoma	0.000201	0.00216	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—SMO—glaucoma	0.000201	0.00216	CbGpPWpGaD
Orlistat—Decreased appetite—Pilocarpine—glaucoma	0.000201	0.00088	CcSEcCtD
Orlistat—Feeling abnormal—Travoprost—glaucoma	0.000201	0.000879	CcSEcCtD
Orlistat—Gastrointestinal pain—Dorzolamide—glaucoma	0.0002	0.000876	CcSEcCtD
Orlistat—Alopecia—Betaxolol—glaucoma	0.0002	0.000875	CcSEcCtD
Orlistat—Palpitations—Clonidine—glaucoma	0.0002	0.000875	CcSEcCtD
Orlistat—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000199	0.000873	CcSEcCtD
Orlistat—Gastrointestinal pain—Travoprost—glaucoma	0.000199	0.000872	CcSEcCtD
Orlistat—Feeling abnormal—Brinzolamide—glaucoma	0.000198	0.000867	CcSEcCtD
Orlistat—Mental disorder—Betaxolol—glaucoma	0.000198	0.000867	CcSEcCtD
Orlistat—Pain—Pilocarpine—glaucoma	0.000198	0.000865	CcSEcCtD
Orlistat—Cough—Clonidine—glaucoma	0.000197	0.000864	CcSEcCtD
Orlistat—Dizziness—Apraclonidine—glaucoma	0.000197	0.000864	CcSEcCtD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000197	0.00211	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000197	0.00211	CbGpPWpGaD
Orlistat—Malnutrition—Betaxolol—glaucoma	0.000197	0.000862	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—PTGFR—glaucoma	0.000195	0.0021	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—MMP1—glaucoma	0.000194	0.00208	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—MMP1—glaucoma	0.000194	0.00208	CbGpPWpGaD
Orlistat—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000194	0.00208	CbGpPWpGaD
Orlistat—Urticaria—Dorzolamide—glaucoma	0.000194	0.000851	CcSEcCtD
Orlistat—Abdominal pain—Dorzolamide—glaucoma	0.000193	0.000846	CcSEcCtD
Orlistat—Body temperature increased—Dorzolamide—glaucoma	0.000193	0.000846	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP2—glaucoma	0.000193	0.00207	CbGpPWpGaD
Orlistat—Sinusitis—Timolol—glaucoma	0.000193	0.000845	CcSEcCtD
Orlistat—Dysgeusia—Betaxolol—glaucoma	0.000193	0.000844	CcSEcCtD
Orlistat—Chest pain—Clonidine—glaucoma	0.000192	0.000843	CcSEcCtD
Orlistat—Abdominal pain—Travoprost—glaucoma	0.000192	0.000843	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000192	0.00206	CbGpPWpGaD
Orlistat—Anxiety—Clonidine—glaucoma	0.000192	0.00084	CcSEcCtD
Orlistat—Asthenia—Acetazolamide—glaucoma	0.000191	0.000838	CcSEcCtD
Orlistat—Dizziness—Bimatoprost—glaucoma	0.000191	0.000837	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000191	0.000837	CcSEcCtD
Orlistat—Urticaria—Brinzolamide—glaucoma	0.000191	0.000836	CcSEcCtD
Orlistat—Feeling abnormal—Pilocarpine—glaucoma	0.00019	0.000834	CcSEcCtD
Orlistat—Discomfort—Clonidine—glaucoma	0.00019	0.000833	CcSEcCtD
Orlistat—Vomiting—Apraclonidine—glaucoma	0.00019	0.00083	CcSEcCtD
Orlistat—Muscle spasms—Betaxolol—glaucoma	0.000189	0.000829	CcSEcCtD
Orlistat—Gastrointestinal pain—Pilocarpine—glaucoma	0.000189	0.000827	CcSEcCtD
Orlistat—Hypersensitivity—Brimonidine—glaucoma	0.000189	0.000826	CcSEcCtD
Orlistat—Dry mouth—Clonidine—glaucoma	0.000188	0.000824	CcSEcCtD
Orlistat—Dermatitis—Apraclonidine—glaucoma	0.000188	0.000823	CcSEcCtD
Orlistat—Headache—Apraclonidine—glaucoma	0.000187	0.000818	CcSEcCtD
Orlistat—DAGLA—Hemostasis—CAV1—glaucoma	0.000186	0.002	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—CAV1—glaucoma	0.000186	0.002	CbGpPWpGaD
Orlistat—Vision blurred—Betaxolol—glaucoma	0.000185	0.000812	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—RPTOR—glaucoma	0.000185	0.00198	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RPTOR—glaucoma	0.000185	0.00198	CbGpPWpGaD
Orlistat—Oedema—Clonidine—glaucoma	0.000184	0.000808	CcSEcCtD
Orlistat—Asthenia—Brimonidine—glaucoma	0.000184	0.000804	CcSEcCtD
Orlistat—Infection—Clonidine—glaucoma	0.000183	0.000803	CcSEcCtD
Orlistat—Abdominal pain—Pilocarpine—glaucoma	0.000183	0.0008	CcSEcCtD
Orlistat—Body temperature increased—Pilocarpine—glaucoma	0.000183	0.0008	CcSEcCtD
Orlistat—Ill-defined disorder—Betaxolol—glaucoma	0.000183	0.0008	CcSEcCtD
Orlistat—Diarrhoea—Acetazolamide—glaucoma	0.000183	0.000799	CcSEcCtD
Orlistat—Rash—Bimatoprost—glaucoma	0.000182	0.000798	CcSEcCtD
Orlistat—Dermatitis—Bimatoprost—glaucoma	0.000182	0.000798	CcSEcCtD
Orlistat—Oedema peripheral—Timolol—glaucoma	0.000182	0.000797	CcSEcCtD
Orlistat—Pruritus—Brimonidine—glaucoma	0.000181	0.000793	CcSEcCtD
Orlistat—Headache—Bimatoprost—glaucoma	0.000181	0.000793	CcSEcCtD
Orlistat—Nervous system disorder—Clonidine—glaucoma	0.000181	0.000792	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—NOS3—glaucoma	0.000181	0.00194	CbGpPWpGaD
Orlistat—Hypersensitivity—Dorzolamide—glaucoma	0.00018	0.000789	CcSEcCtD
Orlistat—PNLIP—Disease—HDAC9—glaucoma	0.00018	0.00193	CbGpPWpGaD
Orlistat—Hypersensitivity—Travoprost—glaucoma	0.000179	0.000785	CcSEcCtD
Orlistat—Skin disorder—Clonidine—glaucoma	0.000179	0.000785	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NCK2—glaucoma	0.000179	0.00192	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NCK2—glaucoma	0.000179	0.00192	CbGpPWpGaD
Orlistat—Hyperhidrosis—Clonidine—glaucoma	0.000178	0.000781	CcSEcCtD
Orlistat—Malaise—Betaxolol—glaucoma	0.000177	0.000777	CcSEcCtD
Orlistat—DAGLB—Hemostasis—FN1—glaucoma	0.000177	0.0019	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—FN1—glaucoma	0.000177	0.0019	CbGpPWpGaD
Orlistat—Nausea—Apraclonidine—glaucoma	0.000177	0.000776	CcSEcCtD
Orlistat—Hypersensitivity—Brinzolamide—glaucoma	0.000177	0.000776	CcSEcCtD
Orlistat—Vertigo—Betaxolol—glaucoma	0.000177	0.000774	CcSEcCtD
Orlistat—Dizziness—Acetazolamide—glaucoma	0.000176	0.000772	CcSEcCtD
Orlistat—Asthenia—Dorzolamide—glaucoma	0.000175	0.000768	CcSEcCtD
Orlistat—Asthenia—Travoprost—glaucoma	0.000175	0.000765	CcSEcCtD
Orlistat—Palpitations—Betaxolol—glaucoma	0.000174	0.000762	CcSEcCtD
Orlistat—Pruritus—Dorzolamide—glaucoma	0.000173	0.000758	CcSEcCtD
Orlistat—Asthenia—Brinzolamide—glaucoma	0.000172	0.000755	CcSEcCtD
Orlistat—Pruritus—Travoprost—glaucoma	0.000172	0.000754	CcSEcCtD
Orlistat—Cough—Betaxolol—glaucoma	0.000172	0.000752	CcSEcCtD
Orlistat—Nausea—Bimatoprost—glaucoma	0.000172	0.000752	CcSEcCtD
Orlistat—FASN—Metabolism—CA1—glaucoma	0.000171	0.00183	CbGpPWpGaD
Orlistat—Hypersensitivity—Pilocarpine—glaucoma	0.00017	0.000745	CcSEcCtD
Orlistat—Pruritus—Brinzolamide—glaucoma	0.00017	0.000745	CcSEcCtD
Orlistat—Vomiting—Acetazolamide—glaucoma	0.00017	0.000743	CcSEcCtD
Orlistat—Dizziness—Brimonidine—glaucoma	0.000169	0.000741	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Clonidine—glaucoma	0.000168	0.000736	CcSEcCtD
Orlistat—Chest pain—Betaxolol—glaucoma	0.000168	0.000734	CcSEcCtD
Orlistat—Myalgia—Betaxolol—glaucoma	0.000168	0.000734	CcSEcCtD
Orlistat—Diarrhoea—Dorzolamide—glaucoma	0.000167	0.000733	CcSEcCtD
Orlistat—Headache—Acetazolamide—glaucoma	0.000167	0.000732	CcSEcCtD
Orlistat—Anxiety—Betaxolol—glaucoma	0.000167	0.000731	CcSEcCtD
Orlistat—Insomnia—Clonidine—glaucoma	0.000167	0.000731	CcSEcCtD
Orlistat—Immune system disorder—Timolol—glaucoma	0.000167	0.000731	CcSEcCtD
Orlistat—Diarrhoea—Travoprost—glaucoma	0.000167	0.000729	CcSEcCtD
Orlistat—Mediastinal disorder—Timolol—glaucoma	0.000166	0.000729	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000166	0.000729	CcSEcCtD
Orlistat—Asthenia—Pilocarpine—glaucoma	0.000166	0.000726	CcSEcCtD
Orlistat—Paraesthesia—Clonidine—glaucoma	0.000166	0.000726	CcSEcCtD
Orlistat—Discomfort—Betaxolol—glaucoma	0.000166	0.000725	CcSEcCtD
Orlistat—FASN—Metabolism—CTSA—glaucoma	0.000165	0.00177	CbGpPWpGaD
Orlistat—Diarrhoea—Brinzolamide—glaucoma	0.000164	0.00072	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000164	0.00176	CbGpPWpGaD
Orlistat—Dry mouth—Betaxolol—glaucoma	0.000164	0.000718	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000164	0.00175	CbGpPWpGaD
Orlistat—Pruritus—Pilocarpine—glaucoma	0.000163	0.000716	CcSEcCtD
Orlistat—Alopecia—Timolol—glaucoma	0.000163	0.000715	CcSEcCtD
Orlistat—Mental disorder—Timolol—glaucoma	0.000162	0.000709	CcSEcCtD
Orlistat—Dizziness—Dorzolamide—glaucoma	0.000162	0.000708	CcSEcCtD
Orlistat—Rash—Brimonidine—glaucoma	0.000161	0.000707	CcSEcCtD
Orlistat—Dermatitis—Brimonidine—glaucoma	0.000161	0.000706	CcSEcCtD
Orlistat—Dizziness—Travoprost—glaucoma	0.000161	0.000705	CcSEcCtD
Orlistat—Malnutrition—Timolol—glaucoma	0.000161	0.000704	CcSEcCtD
Orlistat—Oedema—Betaxolol—glaucoma	0.000161	0.000703	CcSEcCtD
Orlistat—Headache—Brimonidine—glaucoma	0.00016	0.000702	CcSEcCtD
Orlistat—Decreased appetite—Clonidine—glaucoma	0.00016	0.000702	CcSEcCtD
Orlistat—Infection—Betaxolol—glaucoma	0.00016	0.000699	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000159	0.00171	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Clonidine—glaucoma	0.000159	0.000698	CcSEcCtD
Orlistat—Fatigue—Clonidine—glaucoma	0.000159	0.000697	CcSEcCtD
Orlistat—Dizziness—Brinzolamide—glaucoma	0.000159	0.000696	CcSEcCtD
Orlistat—Nausea—Acetazolamide—glaucoma	0.000158	0.000694	CcSEcCtD
Orlistat—PLA2G4A—Platelet homeostasis—NOS3—glaucoma	0.000158	0.0017	CbGpPWpGaD
Orlistat—Diarrhoea—Pilocarpine—glaucoma	0.000158	0.000692	CcSEcCtD
Orlistat—Pain—Clonidine—glaucoma	0.000158	0.000691	CcSEcCtD
Orlistat—Nervous system disorder—Betaxolol—glaucoma	0.000158	0.00069	CcSEcCtD
Orlistat—Dysgeusia—Timolol—glaucoma	0.000157	0.00069	CcSEcCtD
Orlistat—FASN—Metabolism—CA2—glaucoma	0.000156	0.00167	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP2—glaucoma	0.000156	0.00167	CbGpPWpGaD
Orlistat—Skin disorder—Betaxolol—glaucoma	0.000156	0.000683	CcSEcCtD
Orlistat—PNLIP—Metabolism—TXN—glaucoma	0.000156	0.00167	CbGpPWpGaD
Orlistat—Vomiting—Dorzolamide—glaucoma	0.000155	0.000681	CcSEcCtD
Orlistat—Hyperhidrosis—Betaxolol—glaucoma	0.000155	0.00068	CcSEcCtD
Orlistat—Rash—Dorzolamide—glaucoma	0.000154	0.000675	CcSEcCtD
Orlistat—Dermatitis—Dorzolamide—glaucoma	0.000154	0.000674	CcSEcCtD
Orlistat—Rash—Travoprost—glaucoma	0.000153	0.000672	CcSEcCtD
Orlistat—Dermatitis—Travoprost—glaucoma	0.000153	0.000672	CcSEcCtD
Orlistat—Headache—Dorzolamide—glaucoma	0.000153	0.000671	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—RPTOR—glaucoma	0.000153	0.00164	CbGpPWpGaD
Orlistat—Vomiting—Brinzolamide—glaucoma	0.000153	0.000669	CcSEcCtD
Orlistat—Dizziness—Pilocarpine—glaucoma	0.000153	0.000669	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000153	0.00164	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000153	0.00164	CbGpPWpGaD
Orlistat—Headache—Travoprost—glaucoma	0.000153	0.000668	CcSEcCtD
Orlistat—Nausea—Brimonidine—glaucoma	0.000152	0.000666	CcSEcCtD
Orlistat—Feeling abnormal—Clonidine—glaucoma	0.000152	0.000666	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—HDAC9—glaucoma	0.000152	0.00163	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HDAC9—glaucoma	0.000152	0.00163	CbGpPWpGaD
Orlistat—Rash—Brinzolamide—glaucoma	0.000152	0.000664	CcSEcCtD
Orlistat—Vision blurred—Timolol—glaucoma	0.000152	0.000664	CcSEcCtD
Orlistat—Dermatitis—Brinzolamide—glaucoma	0.000151	0.000663	CcSEcCtD
Orlistat—Gastrointestinal pain—Clonidine—glaucoma	0.000151	0.000661	CcSEcCtD
Orlistat—Headache—Brinzolamide—glaucoma	0.000151	0.000659	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—NARFL—glaucoma	0.00015	0.00161	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CA5A—glaucoma	0.00015	0.00161	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NCK2—glaucoma	0.000148	0.00159	CbGpPWpGaD
Orlistat—Angioedema—Timolol—glaucoma	0.000147	0.000643	CcSEcCtD
Orlistat—Vomiting—Pilocarpine—glaucoma	0.000147	0.000643	CcSEcCtD
Orlistat—Urticaria—Clonidine—glaucoma	0.000147	0.000642	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000146	0.000641	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—EDN1—glaucoma	0.000146	0.00157	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—EDN1—glaucoma	0.000146	0.00157	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000146	0.00157	CbGpPWpGaD
Orlistat—Abdominal pain—Clonidine—glaucoma	0.000146	0.000639	CcSEcCtD
Orlistat—Body temperature increased—Clonidine—glaucoma	0.000146	0.000639	CcSEcCtD
Orlistat—Rash—Pilocarpine—glaucoma	0.000146	0.000638	CcSEcCtD
Orlistat—Dermatitis—Pilocarpine—glaucoma	0.000146	0.000637	CcSEcCtD
Orlistat—Insomnia—Betaxolol—glaucoma	0.000145	0.000636	CcSEcCtD
Orlistat—Nausea—Dorzolamide—glaucoma	0.000145	0.000636	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—glaucoma	0.000145	0.00156	CbGpPWpGaD
Orlistat—Headache—Pilocarpine—glaucoma	0.000145	0.000634	CcSEcCtD
Orlistat—Nausea—Travoprost—glaucoma	0.000145	0.000633	CcSEcCtD
Orlistat—Vertigo—Timolol—glaucoma	0.000144	0.000633	CcSEcCtD
Orlistat—Paraesthesia—Betaxolol—glaucoma	0.000144	0.000632	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000143	0.00154	CbGpPWpGaD
Orlistat—Nausea—Brinzolamide—glaucoma	0.000143	0.000625	CcSEcCtD
Orlistat—Palpitations—Timolol—glaucoma	0.000142	0.000622	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000142	0.00152	CbGpPWpGaD
Orlistat—Dyspepsia—Betaxolol—glaucoma	0.000141	0.000619	CcSEcCtD
Orlistat—DAGLB—Hemostasis—NOS3—glaucoma	0.000141	0.00151	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—NOS3—glaucoma	0.000141	0.00151	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000141	0.00151	CbGpPWpGaD
Orlistat—Cough—Timolol—glaucoma	0.00014	0.000614	CcSEcCtD
Orlistat—Decreased appetite—Betaxolol—glaucoma	0.00014	0.000611	CcSEcCtD
Orlistat—Gastrointestinal disorder—Betaxolol—glaucoma	0.000139	0.000607	CcSEcCtD
Orlistat—Fatigue—Betaxolol—glaucoma	0.000138	0.000606	CcSEcCtD
Orlistat—Pain—Betaxolol—glaucoma	0.000137	0.000602	CcSEcCtD
Orlistat—Nausea—Pilocarpine—glaucoma	0.000137	0.000601	CcSEcCtD
Orlistat—Chest pain—Timolol—glaucoma	0.000137	0.000599	CcSEcCtD
Orlistat—Myalgia—Timolol—glaucoma	0.000137	0.000599	CcSEcCtD
Orlistat—Anxiety—Timolol—glaucoma	0.000136	0.000597	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000136	0.000595	CcSEcCtD
Orlistat—Hypersensitivity—Clonidine—glaucoma	0.000136	0.000595	CcSEcCtD
Orlistat—Discomfort—Timolol—glaucoma	0.000135	0.000592	CcSEcCtD
Orlistat—Dry mouth—Timolol—glaucoma	0.000134	0.000586	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—EDN1—glaucoma	0.000133	0.00142	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—EDN1—glaucoma	0.000133	0.00142	CbGpPWpGaD
Orlistat—Asthenia—Clonidine—glaucoma	0.000132	0.00058	CcSEcCtD
Orlistat—Feeling abnormal—Betaxolol—glaucoma	0.000132	0.00058	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000132	0.00142	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000131	0.00141	CbGpPWpGaD
Orlistat—Anaphylactic shock—Timolol—glaucoma	0.000131	0.000575	CcSEcCtD
Orlistat—Oedema—Timolol—glaucoma	0.000131	0.000575	CcSEcCtD
Orlistat—Pruritus—Clonidine—glaucoma	0.000131	0.000572	CcSEcCtD
Orlistat—Infection—Timolol—glaucoma	0.00013	0.000571	CcSEcCtD
Orlistat—Nervous system disorder—Timolol—glaucoma	0.000129	0.000564	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—C3—glaucoma	0.000128	0.00137	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—C3—glaucoma	0.000128	0.00137	CbGpPWpGaD
Orlistat—Urticaria—Betaxolol—glaucoma	0.000128	0.000559	CcSEcCtD
Orlistat—Skin disorder—Timolol—glaucoma	0.000127	0.000558	CcSEcCtD
Orlistat—FASN—Disease—HDAC9—glaucoma	0.000127	0.00136	CbGpPWpGaD
Orlistat—Body temperature increased—Betaxolol—glaucoma	0.000127	0.000556	CcSEcCtD
Orlistat—Hyperhidrosis—Timolol—glaucoma	0.000127	0.000556	CcSEcCtD
Orlistat—Diarrhoea—Clonidine—glaucoma	0.000126	0.000553	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HDAC9—glaucoma	0.000126	0.00135	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000124	0.00133	CbGpPWpGaD
Orlistat—Dizziness—Clonidine—glaucoma	0.000122	0.000534	CcSEcCtD
Orlistat—PNLIP—Metabolism—GSTT1—glaucoma	0.000121	0.00129	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Timolol—glaucoma	0.00012	0.000524	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—SMO—glaucoma	0.000119	0.00127	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SMO—glaucoma	0.000119	0.00127	CbGpPWpGaD
Orlistat—Insomnia—Timolol—glaucoma	0.000119	0.00052	CcSEcCtD
Orlistat—Hypersensitivity—Betaxolol—glaucoma	0.000118	0.000518	CcSEcCtD
Orlistat—Paraesthesia—Timolol—glaucoma	0.000118	0.000516	CcSEcCtD
Orlistat—Vomiting—Clonidine—glaucoma	0.000117	0.000514	CcSEcCtD
Orlistat—Rash—Clonidine—glaucoma	0.000116	0.000509	CcSEcCtD
Orlistat—Dermatitis—Clonidine—glaucoma	0.000116	0.000509	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—C3—glaucoma	0.000116	0.00124	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—C3—glaucoma	0.000116	0.00124	CbGpPWpGaD
Orlistat—Headache—Clonidine—glaucoma	0.000116	0.000506	CcSEcCtD
Orlistat—Dyspepsia—Timolol—glaucoma	0.000116	0.000506	CcSEcCtD
Orlistat—Asthenia—Betaxolol—glaucoma	0.000115	0.000505	CcSEcCtD
Orlistat—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000115	0.00123	CbGpPWpGaD
Orlistat—Decreased appetite—Timolol—glaucoma	0.000114	0.0005	CcSEcCtD
Orlistat—Pruritus—Betaxolol—glaucoma	0.000114	0.000498	CcSEcCtD
Orlistat—Gastrointestinal disorder—Timolol—glaucoma	0.000113	0.000496	CcSEcCtD
Orlistat—Fatigue—Timolol—glaucoma	0.000113	0.000495	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000112	0.00121	CbGpPWpGaD
Orlistat—Pain—Timolol—glaucoma	0.000112	0.000491	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—OPN4—glaucoma	0.000112	0.0012	CbGpPWpGaD
Orlistat—FASN—Metabolism—TXN—glaucoma	0.00011	0.00118	CbGpPWpGaD
Orlistat—Diarrhoea—Betaxolol—glaucoma	0.00011	0.000481	CcSEcCtD
Orlistat—Nausea—Clonidine—glaucoma	0.00011	0.00048	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NTRK2—glaucoma	0.000109	0.00117	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NTRK2—glaucoma	0.000109	0.00117	CbGpPWpGaD
Orlistat—Feeling abnormal—Timolol—glaucoma	0.000108	0.000474	CcSEcCtD
Orlistat—Gastrointestinal pain—Timolol—glaucoma	0.000107	0.00047	CcSEcCtD
Orlistat—Dizziness—Betaxolol—glaucoma	0.000106	0.000465	CcSEcCtD
Orlistat—Urticaria—Timolol—glaucoma	0.000104	0.000457	CcSEcCtD
Orlistat—Body temperature increased—Timolol—glaucoma	0.000104	0.000454	CcSEcCtD
Orlistat—Abdominal pain—Timolol—glaucoma	0.000104	0.000454	CcSEcCtD
Orlistat—Vomiting—Betaxolol—glaucoma	0.000102	0.000447	CcSEcCtD
Orlistat—DAGLB—Hemostasis—VEGFA—glaucoma	0.000102	0.00109	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—VEGFA—glaucoma	0.000102	0.00109	CbGpPWpGaD
Orlistat—Rash—Betaxolol—glaucoma	0.000101	0.000444	CcSEcCtD
Orlistat—Dermatitis—Betaxolol—glaucoma	0.000101	0.000443	CcSEcCtD
Orlistat—Headache—Betaxolol—glaucoma	0.000101	0.000441	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—PTGFR—glaucoma	0.0001	0.00108	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.0001	0.00108	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.95e-05	0.00107	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SMO—glaucoma	9.85e-05	0.00106	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.72e-05	0.00104	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN2B—glaucoma	9.67e-05	0.00104	CbGpPWpGaD
Orlistat—Hypersensitivity—Timolol—glaucoma	9.67e-05	0.000423	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.61e-05	0.00103	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CYP1B1—glaucoma	9.61e-05	0.00103	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ABCA1—glaucoma	9.61e-05	0.00103	CbGpPWpGaD
Orlistat—Nausea—Betaxolol—glaucoma	9.54e-05	0.000418	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—LRP12—glaucoma	9.51e-05	0.00102	CbGpPWpGaD
Orlistat—Asthenia—Timolol—glaucoma	9.41e-05	0.000412	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—NGFR—glaucoma	9.33e-05	0.001	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NGFR—glaucoma	9.33e-05	0.001	CbGpPWpGaD
Orlistat—Pruritus—Timolol—glaucoma	9.28e-05	0.000407	CcSEcCtD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.28e-05	0.000994	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.15e-05	0.000981	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NTRK2—glaucoma	9.01e-05	0.000966	CbGpPWpGaD
Orlistat—Diarrhoea—Timolol—glaucoma	8.98e-05	0.000393	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NTRK1—glaucoma	8.87e-05	0.000951	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NTRK1—glaucoma	8.87e-05	0.000951	CbGpPWpGaD
Orlistat—Dizziness—Timolol—glaucoma	8.68e-05	0.00038	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—FN1—glaucoma	8.66e-05	0.000928	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTT1—glaucoma	8.53e-05	0.000915	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB2—glaucoma	8.46e-05	0.000907	CbGpPWpGaD
Orlistat—Vomiting—Timolol—glaucoma	8.34e-05	0.000365	CcSEcCtD
Orlistat—Rash—Timolol—glaucoma	8.27e-05	0.000362	CcSEcCtD
Orlistat—Dermatitis—Timolol—glaucoma	8.27e-05	0.000362	CcSEcCtD
Orlistat—Headache—Timolol—glaucoma	8.22e-05	0.00036	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CDKN2B—glaucoma	8.17e-05	0.000876	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN2B—glaucoma	8.17e-05	0.000876	CbGpPWpGaD
Orlistat—PNLIP—Disease—MTHFR—glaucoma	8.1e-05	0.000869	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EDN1—glaucoma	7.84e-05	0.000841	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EDN1—glaucoma	7.84e-05	0.000841	CbGpPWpGaD
Orlistat—Nausea—Timolol—glaucoma	7.79e-05	0.000341	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—NGFR—glaucoma	7.73e-05	0.000829	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GSTM1—glaucoma	7.68e-05	0.000823	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—glaucoma	7.67e-05	0.000822	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—glaucoma	7.67e-05	0.000822	CbGpPWpGaD
Orlistat—PNLIP—Disease—APOE—glaucoma	7.55e-05	0.000809	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.52e-05	0.000806	CbGpPWpGaD
Orlistat—PNLIP—Disease—CAV1—glaucoma	7.48e-05	0.000801	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NTRK1—glaucoma	7.35e-05	0.000788	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CA1—glaucoma	7.33e-05	0.000785	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NGF—glaucoma	7.21e-05	0.000772	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NGF—glaucoma	7.21e-05	0.000772	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CTSA—glaucoma	7.1e-05	0.000761	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.07e-05	0.000758	CbGpPWpGaD
Orlistat—PNLIP—Disease—BAD—glaucoma	7.03e-05	0.000754	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.88e-05	0.000737	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—C3—glaucoma	6.85e-05	0.000734	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—C3—glaucoma	6.85e-05	0.000734	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN2B—glaucoma	6.84e-05	0.000733	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCA1—glaucoma	6.8e-05	0.000729	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP1B1—glaucoma	6.8e-05	0.000729	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MTHFR—glaucoma	6.79e-05	0.000728	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN2B—glaucoma	6.77e-05	0.000726	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CA2—glaucoma	6.7e-05	0.000718	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.7e-05	0.000718	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OPN4—glaucoma	6.59e-05	0.000706	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.55e-05	0.000702	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.55e-05	0.000702	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EDN1—glaucoma	6.5e-05	0.000696	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SOD1—glaucoma	6.41e-05	0.000687	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOE—glaucoma	6.38e-05	0.000684	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOE—glaucoma	6.38e-05	0.000684	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOE—glaucoma	6.32e-05	0.000677	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CAV1—glaucoma	6.32e-05	0.000677	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CAV1—glaucoma	6.32e-05	0.000677	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CAV1—glaucoma	6.26e-05	0.000671	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HEYL—glaucoma	6.13e-05	0.000657	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FN1—glaucoma	6.01e-05	0.000645	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FN1—glaucoma	6.01e-05	0.000645	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NGF—glaucoma	5.97e-05	0.00064	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—BAD—glaucoma	5.94e-05	0.000637	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—BAD—glaucoma	5.94e-05	0.000637	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTGFR—glaucoma	5.93e-05	0.000636	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—glaucoma	5.73e-05	0.000615	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—C3—glaucoma	5.68e-05	0.000608	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS3—glaucoma	5.65e-05	0.000606	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.57e-05	0.000597	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTM1—glaucoma	5.43e-05	0.000583	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—glaucoma	5.34e-05	0.000572	CbGpPWpGaD
Orlistat—FASN—Disease—CAV1—glaucoma	5.29e-05	0.000567	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—glaucoma	5.28e-05	0.000566	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CAV1—glaucoma	5.24e-05	0.000561	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—glaucoma	5.17e-05	0.000554	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SMO—glaucoma	5.06e-05	0.000543	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.01e-05	0.000537	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FN1—glaucoma	4.98e-05	0.000534	CbGpPWpGaD
Orlistat—FASN—Disease—BAD—glaucoma	4.97e-05	0.000533	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.95e-05	0.000531	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—BAD—glaucoma	4.92e-05	0.000528	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN1B—glaucoma	4.9e-05	0.000525	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MMP1—glaucoma	4.89e-05	0.000524	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—glaucoma	4.8e-05	0.000515	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOS3—glaucoma	4.78e-05	0.000512	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOS3—glaucoma	4.78e-05	0.000512	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.77e-05	0.000512	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NOS3—glaucoma	4.73e-05	0.000508	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TXN—glaucoma	4.72e-05	0.000506	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CAV1—glaucoma	4.69e-05	0.000503	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RPTOR—glaucoma	4.64e-05	0.000498	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NCK2—glaucoma	4.5e-05	0.000482	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—glaucoma	4.47e-05	0.000479	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—FN1—glaucoma	4.46e-05	0.000478	CbGpPWpGaD
Orlistat—FASN—Metabolism—CAV1—glaucoma	4.43e-05	0.000475	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—glaucoma	4.33e-05	0.000464	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.31e-05	0.000462	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.27e-05	0.000458	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.21e-05	0.000451	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1B—glaucoma	4.14e-05	0.000444	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1B—glaucoma	4.14e-05	0.000444	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—glaucoma	4e-05	0.000429	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.99e-05	0.000428	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—glaucoma	3.96e-05	0.000424	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.94e-05	0.000422	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—glaucoma	3.83e-05	0.000411	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—glaucoma	3.83e-05	0.000411	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HDAC9—glaucoma	3.82e-05	0.00041	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTT1—glaucoma	3.66e-05	0.000392	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—glaucoma	3.66e-05	0.000392	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—glaucoma	3.55e-05	0.00038	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NARFL—glaucoma	3.51e-05	0.000377	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA5A—glaucoma	3.51e-05	0.000377	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1B—glaucoma	3.46e-05	0.000371	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—glaucoma	3.44e-05	0.000369	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—glaucoma	3.44e-05	0.000369	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1B—glaucoma	3.43e-05	0.000368	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—glaucoma	3.35e-05	0.000359	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EDN1—glaucoma	3.34e-05	0.000358	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.19e-05	0.000342	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—glaucoma	3.18e-05	0.00034	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.15e-05	0.000338	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—glaucoma	3.06e-05	0.000328	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMO—glaucoma	2.99e-05	0.000321	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.95e-05	0.000316	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—C3—glaucoma	2.92e-05	0.000313	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCA1—glaucoma	2.92e-05	0.000313	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP1B1—glaucoma	2.92e-05	0.000313	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—glaucoma	2.85e-05	0.000306	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK2—glaucoma	2.74e-05	0.000293	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—glaucoma	2.6e-05	0.000279	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—glaucoma	2.6e-05	0.000279	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—glaucoma	2.55e-05	0.000274	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGFR—glaucoma	2.35e-05	0.000252	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—glaucoma	2.33e-05	0.00025	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK1—glaucoma	2.23e-05	0.000239	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—glaucoma	2.15e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—glaucoma	2.06e-05	0.000221	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN2B—glaucoma	2.06e-05	0.00022	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDN1—glaucoma	1.97e-05	0.000211	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—glaucoma	1.93e-05	0.000207	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—glaucoma	1.92e-05	0.000206	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CAV1—glaucoma	1.9e-05	0.000204	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGF—glaucoma	1.81e-05	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—C3—glaucoma	1.72e-05	0.000185	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA1—glaucoma	1.72e-05	0.000184	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CTSA—glaucoma	1.66e-05	0.000178	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—glaucoma	1.6e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CAV1—glaucoma	1.59e-05	0.00017	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CA2—glaucoma	1.57e-05	0.000168	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FN1—glaucoma	1.51e-05	0.000162	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—BAD—glaucoma	1.49e-05	0.00016	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—glaucoma	1.44e-05	0.000154	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—glaucoma	1.31e-05	0.000141	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—glaucoma	1.2e-05	0.000129	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TXN—glaucoma	1.11e-05	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1B—glaucoma	1.04e-05	0.000112	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—glaucoma	9.64e-06	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—glaucoma	8.66e-06	9.28e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTT1—glaucoma	8.57e-06	9.19e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCA1—glaucoma	6.83e-06	7.32e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP1B1—glaucoma	6.83e-06	7.32e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—glaucoma	6.54e-06	7.01e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—glaucoma	5.46e-06	5.85e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—glaucoma	4.83e-06	5.17e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—glaucoma	4.49e-06	4.82e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CAV1—glaucoma	4.45e-06	4.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—glaucoma	3.37e-06	3.61e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—glaucoma	3.08e-06	3.3e-05	CbGpPWpGaD
